nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Body temperature increased—Fludarabine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Valganciclovir—Mental disorder—Carmustine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Valganciclovir—Malnutrition—Carmustine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Valganciclovir—Cough—Bleomycin—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Valganciclovir—Angiopathy—Vincristine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Valganciclovir—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Valganciclovir—Diarrhoea—Teniposide—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Valganciclovir—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Valganciclovir—Alopecia—Vincristine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Valganciclovir—Coma—Methotrexate—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Valganciclovir—Back pain—Carmustine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Valganciclovir—Discomfort—Bleomycin—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Valganciclovir—Mental disorder—Vincristine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Valganciclovir—Chills—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Valganciclovir—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Valganciclovir—Neoplasm—Methotrexate—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Valganciclovir—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Valganciclovir—Alopecia—Mitoxantrone—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Valganciclovir—Confusional state—Bleomycin—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Valganciclovir—Vision blurred—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Valganciclovir—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Valganciclovir—Tremor—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Valganciclovir—Oedema—Bleomycin—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Valganciclovir—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Valganciclovir—Infection—Bleomycin—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Valganciclovir—Anaemia—Carmustine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Valganciclovir—Back pain—Vincristine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Valganciclovir—Vomiting—Teniposide—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Valganciclovir—Sepsis—Methotrexate—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Valganciclovir—Agitation—Carmustine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Valganciclovir—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Valganciclovir—Asthenia—Fludarabine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Valganciclovir—Dermatitis—Teniposide—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Valganciclovir—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Valganciclovir—Headache—Teniposide—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Valganciclovir—Pruritus—Fludarabine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Valganciclovir—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Valganciclovir—Back pain—Mitoxantrone—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Valganciclovir—Leukopenia—Carmustine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Valganciclovir—Anorexia—Bleomycin—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Valganciclovir—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Valganciclovir—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Valganciclovir—Anaemia—Vincristine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Valganciclovir—Agitation—Vincristine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Valganciclovir—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Valganciclovir—Hypotension—Bleomycin—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Valganciclovir—Diarrhoea—Fludarabine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Valganciclovir—Convulsion—Carmustine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Valganciclovir—Hypertension—Carmustine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Valganciclovir—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Valganciclovir—Nausea—Teniposide—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Valganciclovir—Anaemia—Mitoxantrone—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Valganciclovir—Vertigo—Vincristine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Valganciclovir—Leukopenia—Vincristine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Valganciclovir—Anxiety—Carmustine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Valganciclovir—Paraesthesia—Bleomycin—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Valganciclovir—Malaise—Mitoxantrone—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Valganciclovir—Dyspnoea—Bleomycin—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Valganciclovir—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Valganciclovir—Convulsion—Vincristine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Valganciclovir—Hypertension—Vincristine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Valganciclovir—Confusional state—Carmustine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Valganciclovir—Oedema—Carmustine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Valganciclovir—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Valganciclovir—Decreased appetite—Bleomycin—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Valganciclovir—Cough—Mitoxantrone—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Valganciclovir—Infection—Carmustine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Valganciclovir—Vomiting—Fludarabine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Valganciclovir—Convulsion—Mitoxantrone—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Valganciclovir—Dermatitis—Fludarabine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Valganciclovir—Hypertension—Mitoxantrone—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Valganciclovir—Pain—Bleomycin—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Valganciclovir—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Valganciclovir—Headache—Fludarabine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Valganciclovir—Tachycardia—Carmustine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Valganciclovir—Arthralgia—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Valganciclovir—Anxiety—Mitoxantrone—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Valganciclovir—Discomfort—Mitoxantrone—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Valganciclovir—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Valganciclovir—Oedema—Vincristine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Valganciclovir—Anorexia—Carmustine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Valganciclovir—Infection—Vincristine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Valganciclovir—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Valganciclovir—Confusional state—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Valganciclovir—Nervous system disorder—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Valganciclovir—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Valganciclovir—Hypotension—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Valganciclovir—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Valganciclovir—Oedema—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Valganciclovir—Nausea—Fludarabine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Valganciclovir—Infection—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Valganciclovir—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Valganciclovir—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Valganciclovir—Urticaria—Bleomycin—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Valganciclovir—Anorexia—Vincristine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Valganciclovir—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Valganciclovir—Body temperature increased—Bleomycin—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Valganciclovir—Insomnia—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Valganciclovir—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Valganciclovir—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Valganciclovir—Paraesthesia—Carmustine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Valganciclovir—Hypotension—Vincristine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Dyspnoea—Carmustine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Somnolence—Carmustine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Anorexia—Mitoxantrone—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Ataxia—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Valganciclovir—Decreased appetite—Carmustine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Valganciclovir—Hypotension—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Valganciclovir—Insomnia—Vincristine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Valganciclovir—Paraesthesia—Vincristine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Valganciclovir—Constipation—Carmustine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Valganciclovir—Pain—Carmustine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Valganciclovir—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Valganciclovir—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Valganciclovir—Decreased appetite—Vincristine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Valganciclovir—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Valganciclovir—Somnolence—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Valganciclovir—Feeling abnormal—Carmustine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Valganciclovir—Fatigue—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Valganciclovir—Asthenia—Bleomycin—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Valganciclovir—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Valganciclovir—Pain—Vincristine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Valganciclovir—Constipation—Vincristine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Valganciclovir—Pruritus—Bleomycin—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Valganciclovir—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Valganciclovir—Eosinophilia—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Valganciclovir—Fatigue—Mitoxantrone—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Valganciclovir—Pancreatitis—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Valganciclovir—Pain—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Valganciclovir—Constipation—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Valganciclovir—Body temperature increased—Carmustine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Valganciclovir—Abdominal pain—Carmustine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Valganciclovir—Pancytopenia—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Valganciclovir—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Valganciclovir—Dysuria—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Valganciclovir—Neutropenia—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Valganciclovir—Body temperature increased—Vincristine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Valganciclovir—Abdominal pain—Vincristine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Valganciclovir—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000995	0.000995	CcSEcCtD
Valganciclovir—Urticaria—Mitoxantrone—lymphatic system cancer	0.000988	0.000988	CcSEcCtD
Valganciclovir—Hypersensitivity—Carmustine—lymphatic system cancer	0.000986	0.000986	CcSEcCtD
Valganciclovir—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000983	0.000983	CcSEcCtD
Valganciclovir—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000983	0.000983	CcSEcCtD
Valganciclovir—Pneumonia—Methotrexate—lymphatic system cancer	0.000977	0.000977	CcSEcCtD
Valganciclovir—Vomiting—Bleomycin—lymphatic system cancer	0.000975	0.000975	CcSEcCtD
Valganciclovir—Infestation NOS—Methotrexate—lymphatic system cancer	0.000972	0.000972	CcSEcCtD
Valganciclovir—Infestation—Methotrexate—lymphatic system cancer	0.000972	0.000972	CcSEcCtD
Valganciclovir—Depression—Methotrexate—lymphatic system cancer	0.000969	0.000969	CcSEcCtD
Valganciclovir—Dermatitis—Bleomycin—lymphatic system cancer	0.000966	0.000966	CcSEcCtD
Valganciclovir—Asthenia—Carmustine—lymphatic system cancer	0.00096	0.00096	CcSEcCtD
Valganciclovir—Renal failure—Methotrexate—lymphatic system cancer	0.000955	0.000955	CcSEcCtD
Valganciclovir—Stomatitis—Methotrexate—lymphatic system cancer	0.000947	0.000947	CcSEcCtD
Valganciclovir—Hypersensitivity—Vincristine—lymphatic system cancer	0.000941	0.000941	CcSEcCtD
Valganciclovir—Haematuria—Methotrexate—lymphatic system cancer	0.000926	0.000926	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000919	0.000919	CcSEcCtD
Valganciclovir—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000916	0.000916	CcSEcCtD
Valganciclovir—Asthenia—Vincristine—lymphatic system cancer	0.000916	0.000916	CcSEcCtD
Valganciclovir—Diarrhoea—Carmustine—lymphatic system cancer	0.000915	0.000915	CcSEcCtD
Valganciclovir—Nausea—Bleomycin—lymphatic system cancer	0.00091	0.00091	CcSEcCtD
Valganciclovir—Asthenia—Mitoxantrone—lymphatic system cancer	0.000892	0.000892	CcSEcCtD
Valganciclovir—Dizziness—Carmustine—lymphatic system cancer	0.000885	0.000885	CcSEcCtD
Valganciclovir—Haemoglobin—Methotrexate—lymphatic system cancer	0.000877	0.000877	CcSEcCtD
Valganciclovir—Diarrhoea—Vincristine—lymphatic system cancer	0.000874	0.000874	CcSEcCtD
Valganciclovir—Haemorrhage—Methotrexate—lymphatic system cancer	0.000872	0.000872	CcSEcCtD
Valganciclovir—Hepatitis—Methotrexate—lymphatic system cancer	0.000872	0.000872	CcSEcCtD
Valganciclovir—Pharyngitis—Methotrexate—lymphatic system cancer	0.000866	0.000866	CcSEcCtD
Valganciclovir—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000861	0.000861	CcSEcCtD
Valganciclovir—Urethral disorder—Methotrexate—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Valganciclovir—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000851	0.000851	CcSEcCtD
Valganciclovir—Vomiting—Carmustine—lymphatic system cancer	0.000851	0.000851	CcSEcCtD
Valganciclovir—Dizziness—Vincristine—lymphatic system cancer	0.000845	0.000845	CcSEcCtD
Valganciclovir—Dermatitis—Carmustine—lymphatic system cancer	0.000843	0.000843	CcSEcCtD
Valganciclovir—Visual impairment—Methotrexate—lymphatic system cancer	0.000841	0.000841	CcSEcCtD
Valganciclovir—Headache—Carmustine—lymphatic system cancer	0.000838	0.000838	CcSEcCtD
Valganciclovir—Eye disorder—Methotrexate—lymphatic system cancer	0.000815	0.000815	CcSEcCtD
Valganciclovir—Tinnitus—Methotrexate—lymphatic system cancer	0.000813	0.000813	CcSEcCtD
Valganciclovir—Vomiting—Vincristine—lymphatic system cancer	0.000812	0.000812	CcSEcCtD
Valganciclovir—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00081	0.00081	CcSEcCtD
Valganciclovir—Dermatitis—Vincristine—lymphatic system cancer	0.000805	0.000805	CcSEcCtD
Valganciclovir—Headache—Vincristine—lymphatic system cancer	0.0008	0.0008	CcSEcCtD
Valganciclovir—Nausea—Carmustine—lymphatic system cancer	0.000795	0.000795	CcSEcCtD
Valganciclovir—Angiopathy—Methotrexate—lymphatic system cancer	0.000791	0.000791	CcSEcCtD
Valganciclovir—Vomiting—Mitoxantrone—lymphatic system cancer	0.000791	0.000791	CcSEcCtD
Valganciclovir—Immune system disorder—Methotrexate—lymphatic system cancer	0.000788	0.000788	CcSEcCtD
Valganciclovir—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000786	0.000786	CcSEcCtD
Valganciclovir—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000784	0.000784	CcSEcCtD
Valganciclovir—Chills—Methotrexate—lymphatic system cancer	0.000783	0.000783	CcSEcCtD
Valganciclovir—Headache—Mitoxantrone—lymphatic system cancer	0.000779	0.000779	CcSEcCtD
Valganciclovir—Alopecia—Methotrexate—lymphatic system cancer	0.000771	0.000771	CcSEcCtD
Valganciclovir—Mental disorder—Methotrexate—lymphatic system cancer	0.000764	0.000764	CcSEcCtD
Valganciclovir—Malnutrition—Methotrexate—lymphatic system cancer	0.000759	0.000759	CcSEcCtD
Valganciclovir—Nausea—Vincristine—lymphatic system cancer	0.000759	0.000759	CcSEcCtD
Valganciclovir—Dysgeusia—Methotrexate—lymphatic system cancer	0.000744	0.000744	CcSEcCtD
Valganciclovir—Nausea—Mitoxantrone—lymphatic system cancer	0.000739	0.000739	CcSEcCtD
Valganciclovir—Back pain—Methotrexate—lymphatic system cancer	0.000734	0.000734	CcSEcCtD
Valganciclovir—Vision blurred—Methotrexate—lymphatic system cancer	0.000716	0.000716	CcSEcCtD
Valganciclovir—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000705	0.000705	CcSEcCtD
Valganciclovir—Anaemia—Methotrexate—lymphatic system cancer	0.000702	0.000702	CcSEcCtD
Valganciclovir—Malaise—Methotrexate—lymphatic system cancer	0.000685	0.000685	CcSEcCtD
Valganciclovir—Vertigo—Methotrexate—lymphatic system cancer	0.000682	0.000682	CcSEcCtD
Valganciclovir—Leukopenia—Methotrexate—lymphatic system cancer	0.00068	0.00068	CcSEcCtD
Valganciclovir—Cough—Methotrexate—lymphatic system cancer	0.000663	0.000663	CcSEcCtD
Valganciclovir—Convulsion—Methotrexate—lymphatic system cancer	0.000658	0.000658	CcSEcCtD
Valganciclovir—Arthralgia—Methotrexate—lymphatic system cancer	0.000646	0.000646	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000642	0.000642	CcSEcCtD
Valganciclovir—Discomfort—Methotrexate—lymphatic system cancer	0.000639	0.000639	CcSEcCtD
Valganciclovir—Confusional state—Methotrexate—lymphatic system cancer	0.000625	0.000625	CcSEcCtD
Valganciclovir—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00062	0.00062	CcSEcCtD
Valganciclovir—Infection—Methotrexate—lymphatic system cancer	0.000616	0.000616	CcSEcCtD
Valganciclovir—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000608	0.000608	CcSEcCtD
Valganciclovir—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000607	0.000607	CcSEcCtD
Valganciclovir—Skin disorder—Methotrexate—lymphatic system cancer	0.000602	0.000602	CcSEcCtD
Valganciclovir—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000599	0.000599	CcSEcCtD
Valganciclovir—Anorexia—Methotrexate—lymphatic system cancer	0.000591	0.000591	CcSEcCtD
Valganciclovir—Hypotension—Methotrexate—lymphatic system cancer	0.000579	0.000579	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000565	0.000565	CcSEcCtD
Valganciclovir—Insomnia—Methotrexate—lymphatic system cancer	0.000561	0.000561	CcSEcCtD
Valganciclovir—Paraesthesia—Methotrexate—lymphatic system cancer	0.000556	0.000556	CcSEcCtD
Valganciclovir—Dyspnoea—Methotrexate—lymphatic system cancer	0.000552	0.000552	CcSEcCtD
Valganciclovir—Somnolence—Methotrexate—lymphatic system cancer	0.000551	0.000551	CcSEcCtD
Valganciclovir—Dyspepsia—Methotrexate—lymphatic system cancer	0.000546	0.000546	CcSEcCtD
Valganciclovir—Decreased appetite—Methotrexate—lymphatic system cancer	0.000539	0.000539	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000535	0.000535	CcSEcCtD
Valganciclovir—Fatigue—Methotrexate—lymphatic system cancer	0.000534	0.000534	CcSEcCtD
Valganciclovir—Pain—Methotrexate—lymphatic system cancer	0.00053	0.00053	CcSEcCtD
Valganciclovir—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000511	0.000511	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000507	0.000507	CcSEcCtD
Valganciclovir—Urticaria—Methotrexate—lymphatic system cancer	0.000492	0.000492	CcSEcCtD
Valganciclovir—Abdominal pain—Methotrexate—lymphatic system cancer	0.00049	0.00049	CcSEcCtD
Valganciclovir—Body temperature increased—Methotrexate—lymphatic system cancer	0.00049	0.00049	CcSEcCtD
Valganciclovir—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000457	0.000457	CcSEcCtD
Valganciclovir—Asthenia—Methotrexate—lymphatic system cancer	0.000445	0.000445	CcSEcCtD
Valganciclovir—Pruritus—Methotrexate—lymphatic system cancer	0.000438	0.000438	CcSEcCtD
Valganciclovir—Diarrhoea—Methotrexate—lymphatic system cancer	0.000424	0.000424	CcSEcCtD
Valganciclovir—Dizziness—Methotrexate—lymphatic system cancer	0.00041	0.00041	CcSEcCtD
Valganciclovir—Vomiting—Methotrexate—lymphatic system cancer	0.000394	0.000394	CcSEcCtD
Valganciclovir—Dermatitis—Methotrexate—lymphatic system cancer	0.00039	0.00039	CcSEcCtD
Valganciclovir—Headache—Methotrexate—lymphatic system cancer	0.000388	0.000388	CcSEcCtD
Valganciclovir—Nausea—Methotrexate—lymphatic system cancer	0.000368	0.000368	CcSEcCtD
